1-63532754-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032437.4(EFCAB7):āc.484A>Gā(p.Lys162Glu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000582 in 1,597,210 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032437.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EFCAB7 | NM_032437.4 | c.484A>G | p.Lys162Glu | missense_variant, splice_region_variant | 4/14 | ENST00000371088.5 | NP_115813.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EFCAB7 | ENST00000371088.5 | c.484A>G | p.Lys162Glu | missense_variant, splice_region_variant | 4/14 | 1 | NM_032437.4 | ENSP00000360129.4 | ||
ITGB3BP | ENST00000478138.1 | n.198-3568T>C | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152098Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000887 AC: 21AN: 236672Hom.: 0 AF XY: 0.0000546 AC XY: 7AN XY: 128298
GnomAD4 exome AF: 0.0000353 AC: 51AN: 1444994Hom.: 0 Cov.: 30 AF XY: 0.0000320 AC XY: 23AN XY: 718966
GnomAD4 genome AF: 0.000276 AC: 42AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74432
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 15, 2023 | The c.484A>G (p.K162E) alteration is located in exon 4 (coding exon 3) of the EFCAB7 gene. This alteration results from a A to G substitution at nucleotide position 484, causing the lysine (K) at amino acid position 162 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at